34 results on '"O'Brien M"'
Search Results
2. Immunotherapy in lung cancer
3. Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
4. Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
5. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy.
6. The relationship between vitamin D and chemotherapy-induced toxicity – a pilot study
7. A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer
8. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
9. Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients
10. Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study
11. Time and chemotherapy treatment trends in the treatment of elderly patients (age ⩾70 years) with small cell lung cancer
12. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
13. The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)
14. Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma
15. Serum p53 antibodies: predictors of survival in small-cell lung cancer?
16. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma
17. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial
18. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas
19. Inhibin as a marker for ovarian cancer
20. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study
21. Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck
22. Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.
23. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
24. Where to go with new expensive treatments in NSCLC.
25. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.
26. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
27. Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.
28. High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.
29. Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
30. Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer.
31. 'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.
32. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
33. Hormone replacement therapy as treatment of breast cancer--a phase II study of Org OD 14 (tibilone).
34. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.